Back to MNTA Stock Lookup

MNTA Related Analyst Ratings

Mar 19, 2013 07:19 AM BofA/Merrill Lynch Downgrades Momenta Pharmaceuticals (MNTA) to Underperform

Aug 15, 2012 09:46 AM Questcor (QCOR) Sees Upside on Positive Comments on Generic Acthar

Aug 6, 2012 10:08 AM Canaccord Genuity Comments on Momenta Pharmaceuticals (MNTA)

Aug 3, 2012 10:28 AM Canaccord Genuity Reiterates a 'Hold' on Momenta Pharmaceuticals (MNTA); Q2: First Clarity on Baxter (BAX) Biosimilars Deal

Jul 20, 2012 12:34 PM UPDATE: UBS Downgrades Momenta Pharmaceuticals (MNTA) to Neutral; Negative Court Ruling

Jun 26, 2012 11:05 AM UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock

Jun 25, 2012 12:46 PM UBS Maintains a 'Buy' on Teva Pharma (TEVA); The Decision's In

Jun 25, 2012 09:01 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Win Now A Reality

Jun 25, 2012 08:23 AM UPDATE: Canaccord Genuity Downgrades Momenta Pharmaceuticals (MNTA) to Hold; Negative Copaxone Ruling

May 29, 2012 08:24 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Preview

May 4, 2012 11:42 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Focus Moves to Copaxone Trial

Feb 14, 2012 09:41 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mgmt Meeting Takeaways: FDA Desire to Use 505(j) for M356

Jan 27, 2012 10:22 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar's Enox Back, Copaxone Ruling Next Catalyst

Jan 19, 2012 11:33 AM UBS Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Attractive Despite Upcoming Binary Events

Jan 5, 2012 08:28 AM Bernstein Starts Momenta Pharmaceuticals (MNTA) at Outperform

Jan 4, 2012 11:12 AM Goldman Sachs Highlights Best and Worst in Biotech for 2012

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Dec 13, 2011 08:44 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); SNY vs. FDA on m-enox: New Judge, Same Pro-FDA Sentiment

Nov 8, 2011 08:54 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Q3: We Expect Enox PI to Hold, Generic Copaxone Trial Ruling in Mid-2012

Nov 8, 2011 08:27 AM Goldman Sachs Trims Target on Momenta Pharmaceuticals (MNTA), Lovenox Remains the Focus

Oct 31, 2011 01:29 PM Goldman Sachs Ratchets Price Target On Momenta (MNTA) Higher

Oct 31, 2011 08:24 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); PI Gives at Least ~20 Months' Better Revenues

Oct 25, 2011 08:24 AM Canaccord Genuity Reiterates a 'Buy' on Momenta (MNTA); Lovenox Authorized Generic Launched

Oct 24, 2011 08:51 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); View Post MNTA Management Meeting

Oct 24, 2011 08:39 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Amphastar/WPI Generic Enox TRO Extended, Injunction Ruling Delayed

Oct 10, 2011 08:45 AM Canaccord Genuity on Life Sciences/Biotechnology: Maintains 'Buy' on MNTA & WPI

Sep 22, 2011 01:43 PM Momenta (MNTA) Shares Edge Higher as UBS Issues Intraday Upgrade

Sep 22, 2011 08:37 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Sues Amphastar for Enox Infringement as Copaxone Suit Hearing Ends

Sep 20, 2011 09:59 AM Goldman Sachs Slashes Price Target On Momenta Pharmaceuticals (MNTA) On Amphastar Approval

Sep 20, 2011 09:02 AM Cowen Downgrades Momenta Pharmaceuticals (MNTA) to Neutral

Sep 20, 2011 08:46 AM Canaccord Genuity Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Dark Horse Amphastar Enox Approved: Other Shoe Drops

Sep 20, 2011 06:57 AM BofA/Merrill Lynch Upgrades Momenta Pharmaceuticals (MNTA) to Neutral

Sep 19, 2011 04:00 PM Leerink Swann Cuts Valuation on Momenta Pharmaceuticals (MNTA), Competition Increases

Sep 9, 2011 09:09 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Generic Copaxone Trial -- Day 2

Sep 8, 2011 10:11 AM UBS Maintains a 'Neutral' on Momenta Pharmaceuticals (MNTA); Adjusting PT for Increased Macro Concerns

Sep 8, 2011 08:31 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Generic Copaxone Suit: Strong Defendant Opening Arguments on Noninfringement

Aug 5, 2011 09:00 AM Monness, Crespi, Hardt Upgrades Momenta Pharmaceuticals (MNTA) to Buy

Jul 25, 2011 08:38 AM Needham & Company Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Inequitable Conduct Concluding Arguments; Proof-of-intent Hurdle Considerable

Jul 14, 2011 09:36 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Inequitable Conduct Trial Day 3 Update

Jul 12, 2011 08:19 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Case on Inequitable Conduct Credible, but Legal Hurdle Still High

Jun 28, 2011 11:53 AM BofA/Merrill Lynch Starts Momenta Pharma (MNTA) at Underperform

Jun 20, 2011 09:50 AM Wedbush Reiterates an 'Outperform' on Momenta (MNTA); Potential Upcoming Catalysts Include Copaxone Trial and Partnerships

May 6, 2011 01:42 PM UBS Maintains a 'Neutral' on Momenta Pharmaceuticals (MNTA); Uneventful Quarter

May 6, 2011 11:48 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Strong M-enox Sales Continue

Apr 15, 2011 10:57 AM UPDATE - UBS Initiates Coverage on Momenta Pharmaceuticals (MNTA) with a Neutral; Risk-Reward Appears Appropriately Priced

Apr 15, 2011 07:35 AM UBS Starts Momenta Pharmaceuticals (MNTA) at Neutral

Feb 14, 2011 11:46 AM Shares of Momenta Pharma (MNTA) on the Move Amid Analyst Downgrade

Feb 11, 2011 01:25 PM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Q4/10: M356 Trial Next Moves in H2/11, M-Enox Sales Steady Out

Jan 26, 2011 12:39 PM Canaccord Genuity reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Buy on weakness: Teva's Enox Minor Deficiency Letter, Six-Month Delay, No Fundamental Change

Jan 24, 2011 11:42 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Mylan Copaxone Markman, Gad Patent Update: No Surprises

Back to MNTA Stock Lookup